Increasing cancer cases and the rising use of doxorubicin for cancer treatment are the two prime factors that drive doxorubicin market potential in the region of North America.
Increasing cancer cases and the rising use of doxorubicin for cancer treatment are the two prime factors that drive doxorubicin market potential in the region of North America.
Fact.MR – A Market Research and Competitive Intelligence Provider: Doxorubicin market is expected to witness an impressive growth during the forecast period on the backdrop of surge in prevalence of multiple cancers, significant presence of established healthcare infrastructure in developed economies, and rising awareness of cancer treatments. Growing awareness of breast cancer has resulted in better dignosis and increased demand for treatment as well.
Doxorubicin is a common drug for chemotherapy and a treatment for various types of cancer. This drug is also known as Adriamycin. This drug slows or stops the growth of cancer cells by blocking an enzyme called topo isomerase 2. This drug is required for cancer cells that need this enzyme to divide and grow.
Rapid adoption of Doxil for metastatic breast cancer and major use of Doxil for chemotherapy in breast cancer has increased in recent years and this trend will be prevalent across the forecast period. Due to rise in prevalence of cancer on a global level, so is the demand for chemotherapy medications will rise.
Get Sample PDF of This Research Report with Detailed Table of Content:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7303
High research activities and growing support from governments to increase awareness about cancer will also create lucrative opportunity for doxorubicin vendors during the forecast period.
Surge in adoption of technologically advanced drug delivery systems such as the PEGylated liposomal capsule form, nanoparticle to avoid adverse effects due to conventional doxorubicin formulation is anticipated to boost the market growth.
Market Trends:
“Ovarian Cancer Accounts for Highest Doxorubicin Consumption”
Surge in the incidence of ovarian cancer has been witnessed and this trend is anticipated to majorly influence doxorubicin sales across the globe. Doxil for ovarian cancer treatment has gained major traction in last few years and is expected to follow a similar trend throughout the forecast period.
Liposomal Doxil and carboplatin for treatment of ovarian cancer are used as a combination drugs. The rising incidence of ovarian cancer will further drive demand for all chemotherapy medications that are crucial to the treatment of this disease.
Surge in cases of invasive breast cancer
As per the study conducted by Breast Cancer Organization, it is expected that over 21% of the U.S. women might have invasive ductal carcinoma. Moreover, based on the report published by American Cancer Society, around 231,840 new cases of invasive breast cancer were diagnosed in the US. Surge in incidence of breast cancer cases is witnessed across the globe.
Speak to Analyst:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7303
Regional Growth Avenues:
The United States is the most profitable market for doxorubicin on a global scale and this can be attributed to the surge in incidence of multiple cancers, the presence of developed healthcare infrastructure, and improving awareness of cancer treatments. Rise in government initiatives and rapid adoption of advanced treatments are also expected to offer lucrative opportunities for doxorubicin manufacturers.
Doxorubicin companies are focusing on launching new products in the nation to maximize their revenue generation potential and increase their market presence.
- For instance, in September 2020, Zydus Cadila, a leading name in the doxorubicin market, announced that it had received final approval for the commercialization of its generic Doxorubicin Hydrochloride Liposome injection by the FDA (Food and Drug Administration), which is used for the treatment of cancers in the U.S.
Competitive Analysis
The global endodontic devices market is highly competitive owing to the existence of several key players. Manufacturers have been focusing on growth strategies such as geographic expansion, product launch and approval to establish higher market share.
Various development strategies such as collaborations and new product launches help establish strong market foothold for the players.
For instance, In 2018, Brasseler USA, a key manufacturer of high-quality dental equipment, announced that it had collaborated with cerecdoctors.com to innovate revolutionary procedural methods for use in CEREC procedures.
Quick Buy – Doxorubicin Market Research Report:
https://www.factmr.com/checkout/7303
Key Segments Covered in Doxorubicin Industry Research
- By Formulation:
- Lyophilized Doxorubicin Powder
- Doxorubicin Solution
- By Cancer Type:
- Breast Cancer
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Bladder Cancer
- Stomach Cancer
- Leukemia
- Other Types of Cancers
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
- By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the Doxorubicin Market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.
The study divulges compelling insights on the Doxorubicin Market Analysis by Formulation (Lyophilized Doxorubicin Powder & Doxorubicin Solution) By Type (Breast Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Bladder Cancer, Stomach Cancer & Leukemia) By Distribution Channel & Region – Global Market Insights 2026
Check out more related studies published by Fact.MR Research:
Cancer Profiling Market - The global cancer profiling market is expected to yield significant gains across 2021, as preference for precision-based medicine and high quality oncology care acquires increasing traction. With global cancer burden slated to proliferate, patients and medical practitioners alike are scrambling to offer highly efficacious and long-lasting cancer diagnostics, prompting the entry of numerous service providers.
Cancer RNA Expression Market - Cancer RNA expression plays an important role in the studying mutation patterns and if understood wholly for particular person it may help in speedy recovery and cure. In recent days the gene therapy for cancer treatment is mainly driven by the cancer RNA expression and DNA expression. Cancer RNA expression plays an important role in the PCR sequencing enabling enhanced understanding of different mutations in cancerous cells.
Cancer Genomic Testing Market - The increasing prevalence of breast cancer and lung cancer is primary factor driving the growth of the cancer genomic testing market over the forecast period. Also, the rise in awareness campaign by the NGO’s about cancer will upsurge the revenue growth of cancer genomic testing market.
Cancer Therapeutics Market - Implementation of peptide drugs and peptide therapies in cancer therapeutics landscape has evolved remarkably in the past few years, and incorporating peptide-based drugs in chemotherapy has become a promising way to improve efficacy of cancer treatment today.
Cancer Immunotherapy Market - Prominent regulatory authorities are realizing the importance of disbursing effective therapeutic approaches for cancer. Consequently, governments and healthcare institutions alike are augmenting healthcare spending. Due to the aforementioned factors, the cancer immunotherapy is expected to reach US$ 310 Bn by registering a stupendous CAGR of 10% by the end of the forecast period 2021-2031.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158